生物法生产D-塔格糖的研究进展

D-塔格糖具有多种独特的生理特性与功能,近年来已被发达国家开发作为具有高经济附加值的功能性甜味剂进行销售。D-塔格糖的商业化生产长期以来依赖化学催化法,随着20世纪90年代利用L-阿拉伯糖异构酶(简称L-AI酶)催化D-半乳糖制备D-塔格糖技术的兴起,生物法生产D-塔格糖成为了新的发展趋势。结合笔者所在课题组近年来的研究成果,就D-塔格糖生物法生产工艺的研究现状和前景进行综述与展望。     

稀有糖的生物转化生产策略：Izumoring方法

稀有糖是在自然界中存在但含量极少的一类单糖及衍生物,其在膳食、保健、医药等领域中发挥着重要的功能。本文综述了一种稀有糖的生物转化生产策略----Izumoring方法,即利用D-塔格糖3-差向异构酶、醛糖异构酶和多元醇脱氢酶等进行所有单糖及糖醇之间的相互转化;利用该原则,分别构建了己糖类、戊糖类和丁糖类的Izumoring转化策略,并可获得所有稀有糖的酶反应和生物转化生产途径。同时,展望了稀有糖生物转化生产的研究趋势。     

生物转化生产D-塔格糖的食品级菌种选育及L-阿拉伯糖异构酶的克隆表达

L-阿拉伯糖异构酶(L-arabinose isomerase,L-AI)是一种可以催化D-半乳糖为D-塔格糖的胞内异构化酶。随着塔格糖在食品工业中越来越广泛的应用,能够将半乳糖转化为塔格糖的食品级微生物以及食品级来源的L-AI受到更大的关注。文中从各种酸奶制品、泡菜及其他一些食品中采集不同的样品,筛选出1株具有L-AI酶活的食品级菌株,经过生理生化鉴定以及16S rDNA序列测定,确定该菌株为戊糖片球菌,命名为Pediococcus pentosaceus PC-5。以该菌基因组为模板,克隆L-AI基因,并在大肠杆菌BL21成功地异源表达。表达产物经粗提取后,在40℃下加入Mn2+,使D-半乳糖转化为D-塔格糖的转化率为33%。     

Biotechnological Applications of Acetic Acid Bacteria

The acetic acid bacteria (AAB) have important roles in food and beverage production, as well as in the bioproduction of industrial chemicals. In recent years, there have been major advances in understanding their taxonomy, molecular biology, and physiology, and in methods for their isolation and identification. AAB are obligate aerobes that oxidize sugars, sugar alcohols, and ethanol with the production of acetic acid as the major end product. This special type of metabolism differentiates them from all other bacteria. Recently, the AAB taxonomy has been strongly rearranged as new techniques using 16S rRNA sequence analysis have been introduced. Currently, the AAB are classified in ten genera in the family Acetobacteriaceae. AAB can not only play a positive role in the production of selected foods and beverages, but they can also spoil other foods and beverages. AAB occur in sugar- and alcohol-enriched environments. The difficulty of cultivation of AAB on semisolid media in the past resulted in poor knowledge of the species present in industrial processes. The first step of acetic acid production is the conversion of ethanol from a carbohydrate carried out by yeasts, and the second step is the oxidation of ethanol to acetic acid carried out by AAB. Vinegar is traditionally the product of acetous fermentation of natural alcoholic substrates. Depending on the substrate, vinegars can be classified as fruit, starch, or spirit substrate vinegars. Although a variety of bacteria can produce acetic acid, mostly members of Acetobacter, Gluconacetobacter, and Gluconobacter are used commercially. Industrial vinegar manufacturing processes fall into three main categories: slow processes, quick processes, and submerged processes. AAB also play an important role in cocoa production, which represents a significant means of income for some countries. Microbial cellulose, produced by AAB, possesses some excellent physical properties and has potential for many applications. Other products of biotransformations by AAB or their enzymes include 2-keto-L-gulonic acid, which is used for the production of vitamin C; D-tagatose, which is used as a bulking agent in food and a noncalorific sweetener; and shikimate, which is a key intermediate for a large number of antibiotics. Recently, for the first time, a pathogenic acetic acid bacterium was described, representing the newest and tenth genus of AAB.     

Bacillus Stearothermophilus IAM 11001 L-阿拉伯糖异构酶在大肠杆菌中的表达、纯化及活性研究

L-阿拉伯糖异构酶是生物法生产新型功能性因子D-塔格糖最为有效的酶。本文获得了一种新型耐热L-阿拉伯糖异构酶的编码基因araA,来源于Bacillus stearothermophilis IAM 11001,经NCBI Blastn分析,与GenBank中Thermus sp. IM6501 araA序列的同源性为95%,并将该新基因提交到GenBank,获得登陆号：EU394214。以pET-22b(+)为载体质粒,E. coli BL21(DE3)为宿主细胞,构建了基因重组菌,IPTG可诱导目的蛋白的过量表达;经亲和层析纯化的重组蛋白样品进行SDS-PAGE电泳分析,约在59 kDa处出现显著的特征蛋白条带;同时对重组L-AI的活性进行了初步研究,全细胞反应24小时D-塔格糖的转化率为39.8%。     

联合β-半乳糖苷酶和L-阿拉伯糖异构酶法合成D-塔格糖的研究

将大肠杆菌K-12中的B-半乳糖苷酶基因lacZ和L-阿拉伯糖异构酶基因araA以串联方式克隆到载体pET-28a（＋）上,并转入大肠杆菌BL21（DE3）中进行表达。通过SDS—PAGE分析发现,重组菌株能表达出大量可溶性B．半乳糖苷酶蛋白和L-阿拉伯糖异构酶蛋白。以重悬菌液为酶源,可将乳糖降解为D-半乳糖,并将D-半乳糖转化为D-塔格糖。在温度为50℃,pH7．0的缓冲液中,经一段时间反应后,D-塔格糖的转化率可达21％以上。加入Mn^2＋、Co^2＋和Fe^2＋均能够使D-塔格糖的转化率提高。     

微生物来源的L-阿拉伯糖异构酶的研究进展及应用前景

L-阿拉伯糖异构酶(L-AI)能分别催化L-阿拉伯糖和D-半乳糖异构为L-核酮糖和D-塔格糖,它是目前生物法生产新型功能性因子D-塔格糖最为有效的酶.近年来,L-AI的结构已被揭晓,其基因已获得克隆、测序和过量表达,经过蛋白质工程改造的L-AI将是未来工业化生产D-塔格糖的主要用酶.本文综述了近年来国外对L-AI的结构与功能、催化机理、酶学性质及应用于D-塔格糖生产方面的研究状况,并展望了其发展前景.     

生物制造高附加值乳糖衍生物的研究进展

乳糖来自于乳清,是奶酪行业的低附加值副产物。由于亚洲人普遍存在乳糖不耐受性,因此乳糖缺乏有效的经济增值途径。随着我国乳制品行业的不断发展,利用乳糖制备高附加值产品具有重要的经济价值和产业升级意义。本文就近年来发展的利用生物技术转化乳糖为稀少糖或益生寡糖的方法进行了综述,以期对该领域研究提供借鉴。     

利用固定化重组大肠杆菌细胞生产D-塔格糖

利用经海藻酸钙包埋的重组大肠杆菌细胞催化D-半乳糖生产D-塔格糖,考察了细胞包埋量、反应条件对固定化细胞催化效率以及对D-塔格糖生产稳定性的影响。确定的最优转化条件为:温度65℃,pH 6.5,添加终浓度为1 mmol/L Mn²⁺,底物(D-半乳糖)浓度100 g/L,重组大肠杆菌细胞用量40 g/L。固定化小球在0.3%戊二醛溶液中交联30 min可以显著提高其在高温下的机械强度。考察了异构化反应体系中硼酸与底物间的摩尔比对产率的影响。研究结果表明,添加适量的硼酸可以改变原有的化学反应平衡,实现D-塔格糖的高产。利用D-半乳糖为底物在最优的反应条件下催化24 h,固定化细胞对D-半乳糖的转化率最高,可达65.8%,连续转化8批次的平均转化率为60.6%,为工业化生产D-塔格糖奠定了基础。